Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - OPERATING EXPENSES
Operating Expenses REGN - Regeneron Pharmaceuticals, Inc.
8.24 B
LAST VALUE
21.11%
2 YEAR CAGR
11.09%
5 YEAR CAGR
16.59%
10 YEAR CAGR